Molecular mechanisms of resistance to HER2-targeted therapy

被引：2
|
作者：
Esteva, F. J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH | 2009年 / 11卷
关键词：
HUMAN-BREAST-CANCER; TRASTUZUMAB;
D O I：
10.1186/bcr2283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [1] Molecular mechanisms of resistance to HER2-targeted therapy
    FJ Esteva
    Breast Cancer Research, 11
  • [2] Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer
    Zhang, Rui
    Su, Chang
    Jia, Yongliang
    Xing, Menglu
    Jin, Shuiling
    Zong, Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [3] Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review
    Blange, Dionne
    Stroes, Charlotte I.
    Derks, Sarah
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    CANCER TREATMENT REVIEWS, 2022, 108
  • [4] Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
    Nahta, Rita
    Yu, Dihua
    Hung, Mien-Chie
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05): : 269 - 280
  • [5] Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
    Rita Nahta
    Dihua Yu
    Mien-Chie Hung
    Gabriel N Hortobagyi
    Francisco J Esteva
    Nature Clinical Practice Oncology, 2006, 3 : 269 - 280
  • [6] Resistance to HER2-targeted therapy: mechanisms of trastuzumab resistance and possible strategies to overcome unresponsiveness to treatment
    Hubalek, Michael
    Brunner, Christine
    Matthae, Karin
    Marth, Christian
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (19-20) : 506 - 512
  • [7] HER2-targeted therapy is changing
    Matsumura, Noriomi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 325 - 325
  • [8] HER2-Targeted Therapy in Osteosarcoma
    Gill, Jonathan
    Hingorani, Pooja
    Roth, Michael
    Gorlick, Richard
    CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 : 55 - 66
  • [9] Mechanisms of Resistance to HER2-Targeted Therapies in HER2-positive Breast Cancer
    Veeraraghavan, Jamunarani
    Liao, Fu-Tien
    Qin, Lanfang
    Gordon, Tia
    Raghavan, Alekya
    Sabotta, Caroline
    Kaplan, Rachel
    Gutierrez, Carolina
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    Schiff, Rachel
    CANCER RESEARCH, 2024, 84 (03)
  • [10] The role of PP2A in innate resistance to HER2-targeted therapy
    Conlon, N.
    McDermott, M.
    Crown, J.
    O'Donovan, N.
    ANNALS OF ONCOLOGY, 2016, 27
12345